What does an elevated serum tryptase level suggest?

Elevated Tryptase: Clinical Significance

An elevated serum tryptase level suggests either acute mast cell activation (when measured during a reaction) or an increased mast cell burden (when persistently elevated at baseline), requiring differentiation between systemic mastocytosis, hereditary alpha-tryptasemia, mast cell activation syndrome, or transient elevation during anaphylaxis. 1

Context-Dependent Interpretation

The clinical significance of elevated tryptase depends critically on when and how it was measured:

Acute Elevation (During Symptoms)

• Transient elevation during anaphylaxis or severe allergic reactions indicates mast cell degranulation 1
• Measure acute tryptase (sAT) 30 minutes to 2 hours after symptom onset 2
• Compare to baseline tryptase (sBT) obtained ≥24 hours after resolution 2
• Apply the "20 + 2 rule": An increase of >20% + 2 ng/mL above baseline confirms mast cell activation 3, 2, 4
• An sAT/sBT ratio of ≥1.685 improves diagnostic accuracy for anaphylaxis 2
• Even values below 11.4 ng/mL can indicate mast cell activation if they meet the relative increase criteria (≥135% of baseline) 5

Persistently Elevated Baseline (>20 ng/mL)

This is a minor diagnostic criterion for systemic mastocytosis and requires systematic workup 1:

Primary Differential Diagnoses:

1. Systemic Mastocytosis (SM)

• Persistently elevated tryptase >20 ng/mL in 75% of SM cases 3
• Requires bone marrow biopsy in symptomatic patients with persistent elevation 1
• Look for: recurrent anaphylaxis, urticaria pigmentosa, hepatosplenomegaly, bone pain, GI symptoms
• Bone marrow shows multifocal dense infiltrates (≥15 mast cells in aggregates) with aberrant CD25/CD2 expression 1

2. Hereditary Alpha-Tryptasemia (HαT)

• Autosomal dominant condition with increased TPSAB1 gene copies 1, 6
• Prevalence: ~5% of general population 6
• Baseline tryptase typically >8 ng/mL 4
• Can be asymptomatic or present with variable symptoms mimicking MCAS 6
• Does not require bone marrow biopsy if clinical picture fits and SM features absent 6

3. Mast Cell Activation Syndrome (MCAS)

• Requires recurrent episodes affecting ≥2 organ systems simultaneously 3
• Must document acute tryptase increase (>baseline × 1.2 + 2) on ≥2 occasions during symptomatic episodes 3
• Symptoms must respond to mast cell mediator-blocking agents 3
• Key distinction: episodic (not chronic/persistent) symptoms 3

4. Other Causes

• Other myeloid malignancies 1
• Chronic kidney disease 4
• Obesity 4

Algorithmic Approach to Elevated Tryptase

Step 1: Determine Timing

• During acute reaction? → Obtain baseline tryptase ≥24h later, apply 20+2 rule
• Baseline/screening? → Repeat to confirm persistence

Step 2: If Persistently Elevated (>20 ng/mL)

• Assess for SM clinical features: skin lesions (urticaria pigmentosa), organomegaly, bone pain, recurrent anaphylaxis
• Check CBC, comprehensive metabolic panel (rule out renal disease, other hematologic disorders)
• If symptomatic or concerning features → bone marrow biopsy with immunophenotyping 1

Step 3: If Baseline 8-20 ng/mL

• Consider HαT as most likely explanation 6, 4
• Genetic testing for TPSAB1 copy number if available
• Evaluate symptom pattern: episodic vs. chronic, triggers, organ systems involved

Step 4: If Recurrent Episodic Symptoms

• Document tryptase during acute episodes (not just baseline) 3
• Measure other mediators: urinary N-methylhistamine, 11β-PGF2α, LTE4 3
• Trial of mast cell stabilizers/antihistamines to assess therapeutic response 3

Critical Pitfalls to Avoid

• Never interpret elevated tryptase without clinical context 1
• Chronic/persistent symptoms do not suggest MCAS—look for alternative diagnoses like chronic urticaria or poorly controlled asthma 3
• Normal baseline tryptase does not exclude SM—minority of SM patients have normal levels 1
• Single elevated value during acute reaction is insufficient for MCAS diagnosis—requires documentation on ≥2 occasions 3
• Baseline tryptase >8 ng/mL may be normal in HαT carriers—avoid unnecessary invasive workups 6, 4
• Always compare acute to baseline values—absolute values alone are insufficient 2, 5

When to Pursue Bone Marrow Biopsy

Definite indications:

• Persistently elevated baseline tryptase >20 ng/mL with symptoms 1
• Severe insect sting anaphylaxis in adults 7
• Recurrent idiopathic anaphylaxis 7
• Clinical features suggesting SM (skin lesions, organomegaly, unexplained cytopenias)

Not routinely indicated:

• Isolated baseline tryptase 8-20 ng/mL without concerning features (likely HαT) 6
• Single episode of anaphylaxis with identified trigger and appropriate response to treatment
• Asymptomatic individuals with mildly elevated tryptase